ADTRINIB(Sorafenib)
Therapeutic class: Kinase Inhibitors
- Unresectable hepatocellular carcinoma
- Advanced renal cell carcinoma
- Locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment
200mg tablets
200 mg:- A bottle of 120 , 60 & 30 Capsules- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
- As directed by physician
